Market News

Breaking headlines and analysis across every asset class.

Earnings
MarketBeat • Sep 1, 2026
Corient Private Wealth LP Takes $6.03 Million Position in Evergy Inc. $EVRG

Corient Private Wealth LP has acquired 69,726 shares of Evergy Inc. (NASDAQ:EVRG) during the second quarter, establishing a new position valued at approximately $6.03 million. Institutional investors now own 87.24% of the utility company's stock, and analysts maintain a "Moderate Buy" rating with an average price target of $90.60. Evergy recently surpassed quarterly earnings and revenue expectations and declared a quarterly dividend of $0.695 per share.

Earnings
MarketBeat • Sep 1, 2026
34,850 Shares in Cincinnati Financial Corporation $CINF Acquired by Empowered Funds LLC

Empowered Funds LLC recently acquired 34,850 shares of Cincinnati Financial Corporation (NASDAQ:CINF) valued at approximately $6.45 million. This acquisition is part of broader institutional investment, with institutional investors collectively owning 65.24% of the company. Despite missing the consensus EPS estimate in its latest earnings report, analysts maintain a "Moderate Buy" rating for CINF, with an average price target of $195.40, and the company announced a quarterly dividend of $0.94 pe

Markets
Investing.com Nigeria • Sep 1, 2026
Three Asian Tech Ideas For 2026, According to Morgan Stanley By Investing.com

Morgan Stanley has identified three Asian technology stocks as "actionable ideas" for the remainder of 2026, driven by anticipated major media releases and demand for artificial intelligence. Their top picks include Sony, expected to benefit from a rich content pipeline; CXMT, a Chinese memory chipmaker poised to capitalize on AI and server demand; and APR, a South Korean tech company with potential for valuation recovery from strong sales.

Markets
Investing.com • Sep 1, 2026
Morgan Stanley upgrades Robinhood stock rating on product expansion

Morgan Stanley has upgraded Robinhood Markets (NASDAQ:HOOD) to Overweight from Equalweight and increased its price target to $150.00, citing the company's expanding product capabilities that are improving customer economics and extending growth duration. The firm notes Robinhood's ability to diversify revenue streams beyond funded-account growth, with 13 business lines now generating significant annualized revenue in areas like retirement, banking, and credit cards. This upgrade reflects confide

Markets
AD HOC NEWS • Sep 1, 2026
Albemarle stock holds steady as Chilean strike vote and 2026 lithium guidance shape outlook

Albemarle stock is holding steady despite a potential strike by workers in Chile, which could impact its global lithium supply. The company's 2026 lithium production guidance for its Atacama operations is 70,700 tons LCE, below its nominal capacity, while global lithium demand grew 45% through May 2026. The article discusses mixed valuation signals, labor risks, and the company's diversified portfolio including clear brine fluids.

Markets
AD HOC NEWS • Sep 1, 2026
Evergy stock holds steady as utility volatility cools into late August

Evergy stock has remained stable through late August 2026, even as volatility in the broader utility sector has decreased. This stability underscores Evergy's appeal as a reliable income-generating investment within the S&P 500 utilities, with institutional funds maintaining significant holdings. The company's business model focuses on regulated power services, positioning it as a defensive holding for income-focused investors.

Markets
GuruFocus • Sep 1, 2026
Cboe Global Markets Inc (CBOE) Shares Fall 3.3% -- GF Value Says Still Overvalued

Cboe Global Markets Inc (CBOE) shares dropped 3.3% to $300.20, yet GuruFocus's GF Value still assesses the stock as 31.7% overvalued compared to its intrinsic value estimate of $227.98. Despite a strong GF Score of 92/100, indicating robust fundamentals, the high valuation and insider selling suggest caution for potential investors. The company's P/E ratio is below its historical median, but this does not offset the overall overvaluation.

Markets
Simply Wall Street • Sep 1, 2026
Is Charles River Laboratories International (CRL) Cheap After Its Medigen Vaccine Partnership?

Charles River Laboratories International (CRL) has drawn attention due to its recent partnership with Medigen Vaccine Biologics for next-generation vaccine work, utilizing its biologics testing and Next-Generation Sequencing platforms. While the company has seen a strong share price surge recently (64.91% in 90 days, 76.50% in 1 year), its 5-year return is down 35.88%. The most followed narrative values CRL at $313.61 per share, suggesting it is 8.1% undervalued compared to its recent close of $

Earnings
The Motley Fool • Sep 1, 2026
Vistra CEO James Burke Buys 2,000 Shares After 29% Stock Decline

Vistra Corp. CEO James Burke indirectly purchased 2,000 shares of the company's stock for $270,000 on August 24, 2026, after the stock experienced a 29% decline over the preceding 12 months. This transaction, executed through JAMEB, LP, increases his total beneficial interest to approximately 1.2 million shares, valued at $167.63 million. Burke's purchase signals strong executive confidence in Vistra's valuation, especially after a Q2 earnings report that saw a stock sell-off due to an unrealize

Get Headlines in Your Inbox

One email a day with the market-moving stories you actually need to read.